CLOUDBREAK
LIVE

Serial Number

97786847

Owner

Element Biosciences, Inc.

Attorney

Samantha C. Markley

Filing Date

Feb 8, 2023

Add to watchlist:

No watchlists yet
View on USPTO

CLOUDBREAK Trademark

Serial Number: 97786847

CLOUDBREAK is a trademark filed by Element Biosciences, Inc. on February 8, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Element Biosciences, Inc. (35 trademarks)

9880 Campus Point Drive, Suite 210
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

February 8, 2023

Registration Date

Not Registered

Published for Opposition

February 13, 2024

Goods & Services

Medical diagnostic reagents; reagent kits and beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical medical purposes and diagnostic medical purposes

Providing diagnostic services for others in the fields of science and research related thereto; clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids from human beings

Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits composed primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression in the fields of scientific, diagnostic and clinical research; reagent kits and beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic laboratory purposes

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 27, 2026 EXRA
SOU EXTENSION 3 GRANTED
Jan 26, 2026 EX3G
SOU EXTENSION 3 FILED
Jan 26, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 26, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 25, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jul 24, 2025 EX2G
SOU EXTENSION 2 FILED
Jul 24, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 24, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 4, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jan 22, 2025 EX1G
SOU EXTENSION 1 FILED
Jan 22, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 22, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 30, 2024 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jun 23, 2024 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Mar 13, 2024 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 13, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 13, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 8, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 8, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 8, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 8, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 8, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 8, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 7, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 7, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 7, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 7, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 7, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 7, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 28, 2023 NWOS
NEW APPLICATION ENTERED
Feb 11, 2023 NWAP